Published in J Virol on August 01, 2003
Reovirus induces and benefits from an integrated cellular stress response. J Virol (2006) 1.74
Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo. J Virol (2004) 1.18
Identification of an NF-kappaB-dependent gene network in cells infected by mammalian reovirus. J Virol (2006) 0.99
Bid regulates the pathogenesis of neurotropic reovirus. PLoS Pathog (2010) 0.98
Mechanisms of reovirus-induced cell death and tissue injury: role of apoptosis and virus-induced perturbation of host-cell signaling and transcription factor activation. Viral Immunol (2005) 0.95
NF-kappaB subtypes regulate CCCTC binding factor affecting corneal epithelial cell fate. J Biol Chem (2010) 0.95
Novel nuclear herniations induced by nuclear localization of a viral protein. J Virol (2004) 0.95
Apoptosis induced by mammalian reovirus is beta interferon (IFN) independent and enhanced by IFN regulatory factor 3- and NF-κB-dependent expression of Noxa. J Virol (2011) 0.93
Gene expression in the brain during reovirus encephalitis. J Neurovirol (2010) 0.92
Mechanisms of apoptosis during reovirus infection. Curr Top Microbiol Immunol (2005) 0.92
Non-Biased Enrichment Does Not Improve Quantitative Proteomic Delineation of Reovirus T3D-Infected HeLa Cell Protein Alterations. Front Microbiol (2012) 0.91
Proteomic analysis reveals virus-specific Hsp25 modulation in cardiac myocytes. J Proteome Res (2010) 0.86
Reovirus receptors, cell entry, and proapoptotic signaling. Adv Exp Med Biol (2013) 0.84
Critical role for death-receptor mediated apoptotic signaling in viral myocarditis. J Card Fail (2010) 0.81
Quantification of the host response proteome after mammalian reovirus T1L infection. PLoS One (2012) 0.81
Down-regulation of cFLIP following reovirus infection sensitizes human ovarian cancer cells to TRAIL-induced apoptosis. Apoptosis (2007) 0.81
Genes Induced by Reovirus Infection Have a Distinct Modular Cis-Regulatory Architecture. Curr Genomics (2005) 0.76
HeLa cell response proteome alterations induced by mammalian reovirus T3D infection. Virol J (2013) 0.76
Metabolic changes in type 2 diabetes are reflected in peripheral blood cells, revealing aberrant cytotoxicity, a viral signature, and hypoxia inducible factor activity. BMC Med Genomics (2015) 0.76
Comparative proteomic analyses demonstrate enhanced interferon and STAT-1 activation in reovirus T3D-infected HeLa cells. Front Cell Infect Microbiol (2015) 0.76
Regulators of global genome repair do not respond to DNA damaging therapy but correlate with survival in melanoma. PLoS One (2013) 0.75
PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer. PLoS One (2017) 0.75
The biochemistry of apoptosis. Nature (2000) 18.91
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature (2000) 13.45
Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev (1999) 13.24
CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev (1998) 11.86
Quality control by DNA repair. Science (1999) 7.71
The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell (1997) 5.57
Functions of ceramide in coordinating cellular responses to stress. Science (1996) 5.54
Programmed cell death induced by ceramide. Science (1993) 5.43
Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol (2000) 5.24
Viral strategies of immune evasion. Science (1998) 4.48
Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc Natl Acad Sci U S A (1998) 4.33
DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol (2001) 4.22
Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell (1999) 4.04
Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol (2000) 3.97
Role of PML in cell growth and the retinoic acid pathway. Science (1998) 3.82
PML is essential for multiple apoptotic pathways. Nat Genet (1998) 3.75
GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science (1995) 3.34
Identification of Saccharomyces cerevisiae DNA ligase IV: involvement in DNA double-strand break repair. EMBO J (1997) 3.29
Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol (2000) 3.05
Defying death after DNA damage. Nature (2000) 3.03
Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J Virol (2001) 2.87
Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL. J Exp Med (1999) 2.76
The endoribonuclease activity of mammalian IRE1 autoregulates its mRNA and is required for the unfolded protein response. Genes Dev (2000) 2.72
The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol Cell Biol (2000) 2.69
Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4(+)-T-cell lines. J Virol (2003) 2.46
Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis. Immunity (1999) 2.31
Differences in the capacity of reovirus strains to induce apoptosis are determined by the viral attachment protein sigma 1. J Virol (1995) 2.14
Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events. J Virol (2001) 2.13
Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet (1999) 1.96
Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A. Nat Med (1999) 1.94
Reovirus infection and tissue injury in the mouse central nervous system are associated with apoptosis. J Virol (1997) 1.90
Mammalian GADD34, an apoptosis- and DNA damage-inducible gene. J Biol Chem (1997) 1.85
Reovirus-induced apoptosis of MDCK cells is not linked to viral yield and is blocked by Bcl-2. J Virol (1997) 1.84
Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0. J Virol (1999) 1.84
Heat shock protein 70 inhibits apoptosis downstream of cytochrome c release and upstream of caspase-3 activation. J Biol Chem (2000) 1.83
Apoptosis: an innate immune response to virus infection. Trends Microbiol (1999) 1.82
An endoplasmic reticulum-specific stress-activated caspase (caspase-12) is implicated in the apoptosis of A549 epithelial cells by respiratory syncytial virus. J Cell Biochem (2001) 1.72
Epstein-barr virus-induced changes in B-lymphocyte gene expression. J Virol (2002) 1.72
Reovirus-induced apoptosis requires activation of transcription factor NF-kappaB. J Virol (2000) 1.68
DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis. J Biol Chem (1998) 1.65
Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res (2002) 1.64
Exon skipping in Mcl-1 results in a bcl-2 homology domain 3 only gene product that promotes cell death. J Biol Chem (2000) 1.63
Reovirus-induced apoptosis is mediated by TRAIL. J Virol (2000) 1.62
The cellular response to protein misfolding in the endoplasmic reticulum. Gene Expr (1999) 1.60
Eukaryotic DNA polymerases, a growing family. Trends Biochem Sci (2000) 1.58
Derivation and characterization of an efficiently myocarditic reovirus variant. J Virol (1989) 1.49
The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression. EMBO J (1999) 1.48
Gene expression pattern in Caco-2 cells following rotavirus infection. J Virol (2002) 1.46
Molecular cloning of a novel polypeptide, DP5, induced during programmed neuronal death. J Biol Chem (1997) 1.45
Interaction partners of Dlk/ZIP kinase: co-expression of Dlk/ZIP kinase and Par-4 results in cytoplasmic retention and apoptosis. Oncogene (1999) 1.43
Reovirus binding to cell surface sialic acid potentiates virus-induced apoptosis. J Virol (2001) 1.43
Identification of genes involved in the host response to neurovirulent alphavirus infection. J Virol (2001) 1.39
Microarray analysis of host cell gene transcription in response to varicella-zoster virus infection of human T cells and fibroblasts in vitro and SCIDhu skin xenografts in vivo. J Virol (2003) 1.33
CIPER, a novel NF kappaB-activating protein containing a caspase recruitment domain with homology to Herpesvirus-2 protein E10. J Biol Chem (1999) 1.32
Equine herpesvirus-2 E10 gene product, but not its cellular homologue, activates NF-kappaB transcription factor and c-Jun N-terminal kinase. J Biol Chem (1999) 1.30
Reovirus-induced apoptosis is preceded by increased cellular calpain activity and is blocked by calpain inhibitors. J Virol (1999) 1.30
Reovirus-induced apoptosis requires both death receptor- and mitochondrial-mediated caspase-dependent pathways of cell death. Cell Death Differ (2002) 1.29
Inactivation of the inhibitory kappaB protein kinase/nuclear factor kappaB pathway by Par-4 expression potentiates tumor necrosis factor alpha-induced apoptosis. J Biol Chem (1999) 1.28
Cloning and expression of cDNA encoding the human 150 kDa oxygen-regulated protein, ORP150. Biochem Biophys Res Commun (1997) 1.25
Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals. BMC Biochem (2002) 1.24
Reovirus-induced apoptosis: A minireview. Apoptosis (2003) 1.24
Which DNA polymerases are used for DNA-repair in eukaryotes? Carcinogenesis (1997) 1.23
Reovirus-induced neuronal apoptosis is mediated by caspase 3 and is associated with the activation of death receptors. J Neurovirol (2002) 1.23
Regulation of RNA polymerase II-dependent transcription by poly(ADP-ribosyl)ation of transcription factors. J Biol Chem (1998) 1.19
Reovirus infection activates JNK and the JNK-dependent transcription factor c-Jun. J Virol (2001) 1.18
Reovirus-induced apoptosis requires mitochondrial release of Smac/DIABLO and involves reduction of cellular inhibitor of apoptosis protein levels. J Virol (2002) 1.18
Reoviruses and the host cell. Trends Microbiol (2001) 1.17
Calpain inhibition protects against virus-induced apoptotic myocardial injury. J Virol (2001) 1.17
Caspase-dependent activation of calpain during drug-induced apoptosis. J Biol Chem (1999) 1.16
Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy. Nature (1997) 1.14
Caspase recruitment domain (CARD)-dependent cytoplasmic filaments mediate bcl10-induced NF-kappaB activation. J Cell Biol (2000) 1.14
Implication of calpain in caspase activation during B cell clonal deletion. EMBO J (1999) 1.12
Measles virus-induced modulation of host-cell gene expression. J Gen Virol (2002) 1.11
Procaspase-3 and poly(ADP)ribose polymerase (PARP) are calpain substrates. Biochem Biophys Res Commun (1999) 1.11
CLAP, a novel caspase recruitment domain-containing protein in the tumor necrosis factor receptor pathway, regulates NF-kappaB activation and apoptosis. J Biol Chem (1999) 1.11
The cell death-promoting gene DP5, which interacts with the BCL2 family, is induced during neuronal apoptosis following exposure to amyloid beta protein. J Biol Chem (1999) 1.10
General and specific alterations in programming of global viral gene expression during infection by VP16 activation-deficient mutants of herpes simplex virus type 1. J Virol (2002) 1.06
C-terminal truncation of Dlk/ZIP kinase leads to abrogation of nuclear transport and high apoptotic activity. Oncogene (1999) 1.04
Reovirus-induced alterations in gene expression related to cell cycle regulation. J Virol (2002) 1.03
Studies of the murine DDB1 and DDB2 genes. Gene (2000) 1.03
Pathogenesis of reovirus infections of the central nervous system. Curr Top Microbiol Immunol (1998) 1.03
Caspase 8-dependent sensitization of cancer cells to TRAIL-induced apoptosis following reovirus-infection. Oncogene (2001) 1.02
Apoptosis and the cytopathic effects of reovirus. Curr Top Microbiol Immunol (1998) 1.00
Par-4: an emerging pivotal player in neuronal apoptosis and neurodegenerative disorders. J Mol Neurosci (2000) 0.95
Regulatory mechanisms of TRAF2-mediated signal transduction by Bcl10, a MALT lymphoma-associated protein. J Biol Chem (2000) 0.94
Tyrosine phosphorylation of the Bcl-2-associated protein BNIP-2 by fibroblast growth factor receptor-1 prevents its binding to Cdc42GAP and Cdc42. J Biol Chem (1999) 0.93
Pro-apoptotic action of PAR-4 involves inhibition of NF-kappaB activity and suppression of BCL-2 expression. J Neurosci Res (2000) 0.92
mu-Calpain activation, DNA fragmentation, and synergistic effects of caspase and calpain inhibitors in protecting hippocampal neurons from ischemic damage. Brain Res (2000) 0.92
Ceramide and apoptosis. Biochem Soc Trans (1999) 0.90
Caspases cleave the amino-terminal calpain inhibitory unit of calpastatin during apoptosis in human Jurkat T cells. J Biochem (2000) 0.90
Anisoosmotic regulation of the Mi-2 autoantigen mRNA in H4IIE rat hepatoma cells and primary hepatocytes. FEBS Lett (1998) 0.88
Effects of echovirus 1 infection on cellular gene expression. Virology (2000) 0.88
The human Pim-2 proto-oncogene and its testicular expression. Biochim Biophys Acta (1998) 0.87
The identification and purification of a novel mammalian DNA ligase. Mutat Res (1997) 0.87
C-terminal trimerization, but not N-terminal trimerization, of the reovirus cell attachment protein Is a posttranslational and Hsp70/ATP-dependent process. J Biol Chem (1996) 0.86
Regions essential for the interaction between Bcl-2 and SMN, the spinal muscular atrophy disease gene product. Cell Death Differ (2000) 0.80
Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med (2005) 7.54
Coordination of Rho GTPase activities during cell protrusion. Nature (2009) 6.54
Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer. Cell (2012) 3.77
Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat Rev Mol Cell Biol (2002) 3.46
Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock. Nat Cell Biol (2003) 3.26
Does Toll-like receptor 3 play a biological role in virus infections? Virology (2004) 2.73
Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch Neurol (2004) 2.71
CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum Mol Genet (2005) 2.52
West Nile virus neuroinvasive disease. Ann Neurol (2006) 2.42
Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model. Am J Pathol (2005) 2.39
Steroid-responsive encephalopathy associated with autoimmune thyroiditis and primary CNS demyelination. J Neurol Sci (2004) 2.35
Structural and evolutionary division of phosphotyrosine binding (PTB) domains. J Mol Biol (2005) 2.19
Proteomic identification of the cerebral cavernous malformation signaling complex. J Proteome Res (2007) 1.83
Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch Neurol (2011) 1.83
Combined PI3K/mTOR and MEK inhibition provides broad antitumor activity in faithful murine cancer models. Clin Cancer Res (2012) 1.74
MAP3K4/CBP-regulated H2B acetylation controls epithelial-mesenchymal transition in trophoblast stem cells. Cell Stem Cell (2011) 1.71
Pediatric brainstem gangliogliomas show overexpression of neuropeptide prepronociceptin (PNOC) by microarray and immunohistochemistry. Pediatr Blood Cancer (2012) 1.57
The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy. J Clin Invest (2002) 1.56
Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype. J Biol Chem (2010) 1.51
Inhibitors paradoxically prime kinases. Nat Chem Biol (2009) 1.50
Herpesvirus infections of the nervous system. Nat Clin Pract Neurol (2007) 1.48
Sequential activation of caspases and serine proteases (serpases) during apoptosis. Cell Cycle (2002) 1.46
Molecular methods for diagnosis of viral encephalitis. Clin Microbiol Rev (2004) 1.42
Quantitative CSF PCR in Epstein-Barr virus infections of the central nervous system. Ann Neurol (2002) 1.38
Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer. Cell Cycle (2011) 1.34
MEK kinase 2 and the adaptor protein Lad regulate extracellular signal-regulated kinase 5 activation by epidermal growth factor via Src. Mol Cell Biol (2003) 1.29
Inhibition of Src family kinases blocks epidermal growth factor (EGF)-induced activation of Akt, phosphorylation of c-Cbl, and ubiquitination of the EGF receptor. J Biol Chem (2002) 1.28
Autosomal dominant diffuse leukoencephalopathy with neuroaxonal spheroids. Neurology (2000) 1.28
MEKK1 regulates calpain-dependent proteolysis of focal adhesion proteins for rear-end detachment of migrating fibroblasts. EMBO J (2003) 1.27
Glutathione binding to the Bcl-2 homology-3 domain groove: a molecular basis for Bcl-2 antioxidant function at mitochondria. J Biol Chem (2007) 1.26
PB1 domain interaction of p62/sequestosome 1 and MEKK3 regulates NF-kappaB activation. J Biol Chem (2009) 1.24
Dual infections of the central nervous system with Epstein-Barr virus. J Infect Dis (2004) 1.24
Cerebral cavernous malformation 2 protein promotes smad ubiquitin regulatory factor 1-mediated RhoA degradation in endothelial cells. J Biol Chem (2009) 1.23
The in vitro production and characterization of neutrophils from embryonic stem cells. Blood (2003) 1.23
Reovirus-induced neuronal apoptosis is mediated by caspase 3 and is associated with the activation of death receptors. J Neurovirol (2002) 1.23
Discovery of Novel Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia. ACS Med Chem Lett (2012) 1.22
Bell's palsy--is glucocorticoid treatment enough? N Engl J Med (2007) 1.22
West Nile virus meningoencephalitis. Nat Clin Pract Neurol (2006) 1.22
Ablation of MEKK4 kinase activity causes neurulation and skeletal patterning defects in the mouse embryo. Mol Cell Biol (2005) 1.21
Ubiquitylation of MEKK1 inhibits its phosphorylation of MKK1 and MKK4 and activation of the ERK1/2 and JNK pathways. J Biol Chem (2002) 1.20
Trophoblast stem cell maintenance by fibroblast growth factor 4 requires MEKK4 activation of Jun N-terminal kinase. Mol Cell Biol (2009) 1.19
Progressive multifocal leukoencephalopathy, efalizumab, and immunosuppression: a cautionary tale for dermatologists. Arch Dermatol (2009) 1.19
Apoptosis in animal models of virus-induced disease. Nat Rev Microbiol (2009) 1.19
Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo. J Virol (2004) 1.18
Reovirus-induced apoptosis requires mitochondrial release of Smac/DIABLO and involves reduction of cellular inhibitor of apoptosis protein levels. J Virol (2002) 1.18
Use of PCR for the diagnosis of herpesvirus infections of the central nervous system. J Clin Virol (2002) 1.17
Roles for TAB1 in regulating the IL-1-dependent phosphorylation of the TAB3 regulatory subunit and activity of the TAK1 complex. Biochem J (2008) 1.15
Two distinct phases of virus-induced nuclear factor kappa B regulation enhance tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in virus-infected cells. J Biol Chem (2003) 1.14
Isolation and molecular characterization of a novel type 3 reovirus from a child with meningitis. J Infect Dis (2004) 1.14
Efficiently identifying genome-wide changes with next-generation sequencing data. Nucleic Acids Res (2011) 1.14
PB1 domains of MEKK2 and MEKK3 interact with the MEK5 PB1 domain for activation of the ERK5 pathway. J Biol Chem (2003) 1.13
JNK regulates the release of proapoptotic mitochondrial factors in reovirus-infected cells. J Virol (2004) 1.13
Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer. J Clin Oncol (2010) 1.12
MEKK1 mediates the ubiquitination and degradation of c-Jun in response to osmotic stress. Mol Cell Biol (2006) 1.12
MEKK1 is essential for cardiac hypertrophy and dysfunction induced by Gq. Proc Natl Acad Sci U S A (2002) 1.11
Minocycline delays disease onset and mortality in reovirus encephalitis. Exp Neurol (2005) 1.11
Recurrent dermatomal vesicular skin lesions: a clue to diagnosis of herpes simplex virus 2 meningitis. Arch Neurol (2003) 1.09
MEKK2 regulates the coordinate activation of ERK5 and JNK in response to FGF-2 in fibroblasts. J Cell Physiol (2004) 1.09
Regional differences in viral growth and central nervous system injury correlate with apoptosis. J Virol (2004) 1.08
Integrated activation of MAP3Ks balances cell fate in response to stress. J Cell Biochem (2007) 1.07
PB1 domain-dependent signaling complex is required for extracellular signal-regulated kinase 5 activation. Mol Cell Biol (2006) 1.07
Role of the amino-terminal domains of MEKKs in the activation of NF kappa B and MAPK pathways and in the regulation of cell proliferation and apoptosis. Cell Signal (2002) 1.05
The uninvited guest: JC virus infection of neurons in PML. Neurology (2003) 1.05
Reovirus-induced alterations in gene expression related to cell cycle regulation. J Virol (2002) 1.03
MEKK4 stimulation of p38 and JNK activity is negatively regulated by GSK3beta. J Biol Chem (2007) 1.03
Progressive multifocal leukoencephalopathy: can we reduce risk in patients receiving biological immunomodulatory therapies? Ann Neurol (2010) 1.03
A multicenter, phase I, dose-escalation study to assess the safety, tolerability, and pharmacokinetics of etirinotecan pegol in patients with refractory solid tumors. Clin Cancer Res (2012) 1.01
Impact of rituximab-associated B-cell defects on West Nile virus meningoencephalitis in solid organ transplant recipients. Clin Transplant (2009) 1.01
Novel strategy for treatment of viral central nervous system infection by using a cell-permeating inhibitor of c-Jun N-terminal kinase. J Virol (2007) 1.01
Progressive multifocal leukoencephalopathy and apoptosis of infected oligodendrocytes in the central nervous system of patients with and without AIDS. Arch Neurol (2002) 1.01
Central nervous system apoptosis in human herpes simplex virus and cytomegalovirus encephalitis. J Infect Dis (2002) 1.01
The dynamic nature of the kinome. Biochem J (2013) 1.00
High expression of BMP pathway genes distinguishes a subset of atypical teratoid/rhabdoid tumors associated with shorter survival. Neuro Oncol (2011) 1.00
MEKK4 is an effector of the embryonic TRAF4 for JNK activation. J Biol Chem (2005) 1.00
Wiring diagrams of MAPK regulation by MEKK1, 2, and 3. Biochem Cell Biol (2004) 1.00
Bone morphogenetic protein and retinoic acid-inducible neural specific protein-3 is expressed in gonadotrope cell pituitary adenomas and induces proliferation, migration, and invasion. Endocrinology (2006) 0.99
Application of multiplexed kinase inhibitor beads to study kinome adaptations in drug-resistant leukemia. PLoS One (2013) 0.99
Phase II trial of nanoparticle albumin-bound paclitaxel, carboplatin, and bevacizumab in first-line patients with advanced nonsquamous non-small cell lung cancer. J Thorac Oncol (2009) 0.99
Laser-scanning velocimetry: a confocal microscopy method for quantitative measurement of cardiovascular performance in zebrafish embryos and larvae. BMC Biotechnol (2007) 0.98
West Nile virus growth is independent of autophagy activation. Virology (2012) 0.97
Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications. J Neuropathol Exp Neurol (2001) 0.97
Fas-mediated apoptotic signaling in the mouse brain following reovirus infection. J Virol (2009) 0.97
JAK-STAT signaling pathways are activated in the brain following reovirus infection. J Neurovirol (2007) 0.95
Novel nuclear herniations induced by nuclear localization of a viral protein. J Virol (2004) 0.95
Nonstructural protein sigma1s is a determinant of reovirus virulence and influences the kinetics and severity of apoptosis induction in the heart and central nervous system. J Virol (2005) 0.95
Neuro-intensive care of patients with acute CNS infections. Neurotherapeutics (2012) 0.94
Reovirus infection of the CNS enhances iNOS expression in areas of virus-induced injury. Exp Neurol (2005) 0.94
MEKK1 regulates the AP-1 dimer repertoire via control of JunB transcription and Fra-2 protein stability. Oncogene (2005) 0.94
MicroRNA 9-3p targets β1 integrin to sensitize claudin-low breast cancer cells to MEK inhibition. Mol Cell Biol (2013) 0.94
Cerebral cavernous malformation is a vascular disease associated with activated RhoA signaling. Biol Chem (2013) 0.94
DEVDase detection in intact apoptotic cells using the cell permeant fluorogenic substrate, (z-DEVD)2-cresyl violet. Biotechniques (2003) 0.94
Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study. Arch Neurol (2009) 0.93
SWI/SNF chromatin-remodeling factor Smarcd3/Baf60c controls epithelial-mesenchymal transition by inducing Wnt5a signaling. Mol Cell Biol (2013) 0.93
Daxx upregulation within the cytoplasm of reovirus-infected cells is mediated by interferon and contributes to apoptosis. J Virol (2013) 0.93